Führungsebene
Unser interkulturelles Executive-Team besteht aus Experten aus Medizin und Technologie, die für Glooko medizinische Innovation und wirtschaftlichen Erfolg in Einklang bringen
Russ Johannesson
Chief Executive Officer
Komathi Stem
Chief Operating Officer
Mark Clements, M.D., Ph.D.
Chief Medical Officer
Stephen Lien
Chief Financial Officer
Prakash Menon
Chief Technology Officer
David Conn
Executive Vice President of Partnerships & Alliances
Ed Marshall
Chief Product Officer
Vorstand
Unserem Vorstand gehören Führungskräfte und Gründer an, die Glooko unterstützen und beraten, sodass wir weltweit führend in den Bereichen Datenmanagement und Telemedizin für Menschen mit Diabetes und chronischen Folgeerkrankungen sind
Simon Chong
Co-Founder and Managing Partner, Georgian Partners / Board Member
Yogen Dalal
Founder, Glooko / Board Member
Russ Johannesson
Chief Executive Officer, Glooko / Board Member
Wende Hutton
General Partner, Canaan Partners / Board Member
Tracy Bahl
OneOncology, CVS, General Atlantic, Emdeon, UHG / Board Member
Charles Boorady
Founder & Managing Partner, Health Catalyst Capital / Board Member
Alfonso (Chito) Zulueta
Board Director of CTS Corp., Syneos Health, Inc., CALIDI BioTherapeutics;
Retired-President, International at Eli Lilly and Company /
Board Member
Medizinischer Beirat
Mark Clements, M.D., Ph.D.
Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children’s Mercy Kansas City
Jerome Fischer, M.D.
Partner, Diabetes and Glandular Disease (DGD) Clinic
Michael Greenfield, M.D.
Endocrinologist, El Camino Hospital
David Kerr, M.D.
Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute
